News
SRDX
19.04
+1.93%
0.36
Surmodics Inc: Notice of Effectiveness
Press release · 05/30 11:10
Top 5 Health Care Stocks That Could Blast Off In May
Benzinga · 05/26 12:56
Surmodics Inc: Specialized disclosure report
Press release · 05/25 22:10
Here's Why SurModics (SRDX) Is a Great 'Buy the Bottom' Stock Now
NASDAQ · 05/16 13:55
Surmodics files for $200M mixed shelf offering
Seeking Alpha · 05/12 21:46
BRIEF-Surmodics Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Reuters · 05/12 20:03
Surmodics (SRDX) Q2 Earnings Top Estimates, FY23 View Revised
NASDAQ · 04/27 14:29
SurModics (SRDX) Gets a Buy from Barrington
TipRanks · 04/27 13:35
Earnings Scheduled For April 26, 2023
Benzinga · 04/26 11:13
BRIEF-Surmodics Reports Second Quarter Of Fiscal Year 2023 Financial Results
Reuters · 04/26 11:03
Surmodics Q2 Adjusted EPS $(0.40) Beats $(0.48) Estimate, Sales $27.20M Beat $25.86M Estimate
Benzinga · 04/26 11:02
-- Earnings Flash (SRDX) SURMODICS Reports Q2 Revenue $27.2M, vs. Street Est of $25.9M
-- Earnings Flash (SRDX) SURMODICS Reports Q2 Revenue $27.2M, vs. Street Est of $25.9M
MT Newswires · 04/26 07:13
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), SurModics (SRDX) and Accelerate Diagnostics (AXDX)
TipRanks · 04/25 13:20
BRIEF-Surmodics Enrolled First Patient In Study Using Pounce Thrombectomy System
Reuters · 04/20 12:22
Surmodics Says First Patient Enrolled in PROWL Registry Study
Surmodics Says First Patient Enrolled in PROWL Registry Study
MT Newswires · 04/20 10:02
BRIEF-Surmodics Announces Successful First Patient Use Of Sublime Radial Access Microcatheter
Reuters · 04/19 11:11
Surmodics Reports First Use of Sublime Radial Access Microcatheter
Surmodics Reports First Use of Sublime Radial Access Microcatheter
MT Newswires · 04/19 08:57
ADMA, AMTX and SGH are among after hour movers
Seeking Alpha · 04/06 21:02
Here's Why You Should Retain Surmodics (SRDX) Stock for Now
NASDAQ · 04/06 14:35
Neogen (NEOG) Q3 Earnings Beat Estimates
NASDAQ · 03/30 12:15
More
Webull provides a variety of real-time SRDX stock news. You can receive the latest news about Surmodics Inc through multiple platforms. This information may help you make smarter investment decisions.
About SRDX
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment manufactures performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilizers, substrates, surface coatings and antigens.